Sterling Technology has introduced Tegricel™, a novel nutriceutical (patent pending) at the SupplySide West trade show in Las Vegas.
Tegricel™ has been shown in trials to modulate inflammation due to the use of NSAID’s (Aspirin, Ibuprofen, Etc.) and other conditions caused by Inflammatory Bowel Disease. Tegricel™ is a blend of bioactives in specified levels to achieve maximum benefit to the consumer.
Tegricel™ is manufactured by Sterling Technology, the leading colostrum and bioactive peptide producing company in the United States. ColostruMune™ is colostrum powder product available that aids in immune function and sports nutrition. For additional information contact Sterling Technology at 800-522-3699 or email@example.com.